Raquel Golanski serves as the Director of Life Science Partnerships at Inspire, where she leverages her extensive background in pharmaceutical consulting to forge strategic collaborations that enhance patient engagement and real-world evidence (RWE) initiatives. With a profound commitment to advancing healthcare, Raquel plays a pivotal...
Raquel Golanski serves as the Director of Life Science Partnerships at Inspire, where she leverages her extensive background in pharmaceutical consulting to forge strategic collaborations that enhance patient engagement and real-world evidence (RWE) initiatives. With a profound commitment to advancing healthcare, Raquel plays a pivotal role in connecting life science companies with Inspire's vast online health community, enabling them to gain critical insights into patient experiences and treatment outcomes. Her expertise in RWE is particularly valuable as it allows organizations to harness data-driven insights that inform clinical development and commercialization strategies.
At Inspire, Raquel leads key projects that focus on integrating artificial intelligence (AI) into patient engagement platforms, enhancing the ability of life science companies to analyze real-world data effectively. By fostering strategic partnerships, she not only drives revenue and profit growth for Inspire but also empowers pharmaceutical organizations to make informed decisions that ultimately improve patient care. Her skills in account management and sales prospecting are instrumental in identifying and nurturing relationships with key stakeholders in the healthcare ecosystem.
Raquel's passion for the healthcare industry is complemented by her first-hand clinical knowledge, which she utilizes to bridge the gap between patients and life science companies. By creating a collaborative environment where patients can share their experiences and insights, she ensures that the voice of the patient is at the forefront of therapeutic development. Her work at Inspire exemplifies her dedication to transforming the landscape of healthcare through innovative solutions that prioritize patient engagement and real-world evidence.
